09/01/2020 |
Researcher Jelani Zarif received a career transition award (K22) from the National Cancer Institute to help prostate cancer patients by using macrophages to lower the defense system in cancer and allow therapy into a tumor to destroy it.
jueves, 3 de septiembre de 2020
Jelani Zarif - Cancer Researcher: Image Details - NCI Visuals Online
Jelani Zarif - Cancer Researcher: Image Details - NCI Visuals Online
Researcher Jelani Zarif received a career transition award (K22) from the National Cancer Institute to help prostate cancer patients by using macrophages to lower the defense system in cancer and allow therapy into a tumor to destroy it.
Researcher Jelani Zarif received a career transition award (K22) from the National Cancer Institute to help prostate cancer patients by using macrophages to lower the defense system in cancer and allow therapy into a tumor to destroy it.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario